Neurocrine Biosciences
NBIX
#1205
Rank
โ‚น1.342 T
Marketcap
โ‚น13,263
Share price
1.73%
Change (1 day)
12.15%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.41

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น169.59. In 2022 the company made an earnings per share (EPS) of โ‚น139.31 an increase over its 2021 EPS that were of โ‚น82.20.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.4116.58%
2022โ‚น139.3169.47%
2021โ‚น82.20-78.21%
2020โ‚น377.25990%
2019โ‚น34.6181.82%
2018โ‚น19.04-113.5%
2017-โ‚น141.040.62%
2016-โ‚น140.1757.28%
2015-โ‚น89.1225.61%
2014-โ‚น70.9518.84%
2013-โ‚น59.70-1085.71%
2012โ‚น6.06-89.71%
2011โ‚น58.84-500%
2010-โ‚น14.71-86.92%
2009-โ‚น112.48-43.48%
2008-โ‚น199.01-57.8%
2007-โ‚น471.5692.58%
2006-โ‚น244.87371.67%
2005-โ‚น51.92-52.76%
2004-โ‚น109.8936.56%
2003-โ‚น80.47-70%
2002-โ‚น268.23118.31%
2001-โ‚น122.878.4%
2000-โ‚น113.3548.86%
1999-โ‚น76.14-20%
1998-โ‚น95.18-479.31%
1997โ‚น25.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น180.84 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น47.59-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-โ‚น256.11-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น469.77 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น318.47 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น160.94-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น40.67-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น262.17-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA